CD33 SPLICE SITE GENOTYPE WAS NOT ASSOCIATED WITH OUTCOMES OF PATIENTS RECEIVING THE ANTI-CD33 DRUG CONJUGATE SGN-CD33A

Michele Stanchina

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility